East Sussex LPC Conference - NPA Runs Workshop, UK At the East Sussex Local Pharmaceutical Committee (LPC) Conference held on Sunday 1 March, Helen Rhodes, NPA Professional Services Manager, facilitated a workshop on building relationships with GPs. She was supported by local GP, Dr Bruce Packham. The Conference theme was 'Facing the Future Together'.
Source: www.medicalnewstoday.comPCMA: New Bipartisan Biogenerics Legislation The 'Right Approach' To Increase Competition, Lower Costs Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement supporting HR 1427, "The Promoting Innovation and Access to Life-Saving Medicine Act"- bipartisan legislation introduced by U.S. House Energy and Commerce Committee Chairman Henry Waxman (D-CA), Representatives Nathan Deal (R-GA), Frank Pallone (D-NJ), and Jo Ann Emerson (R-MO)-which would create a regulatory pathway to approve generic versions of biologic products.
Source: www.medicalnewstoday.comObama Overstates Benefits Of EHRs, According To Opinion Piece The "flagship proposal" presented by President Obama at last week's health care summit was the national adoption of electronic health records, but EHRs are "an overly simplistic and unsubstantiated part of the solution" to problems with the U.S. health care system, Jerome Groopman and Pamela Hartzband, staff members at
Source: www.medicalnewstoday.comManhattan Institute Scholars Propose New Compensation Program For Injured Drug Users In a new report released, "In the Wake of Wyeth v. Levine: Making the Case for
FDA Preemption and Administrative Compensation," Manhattan Institute scholars Paul Howard and James Copland respond to the recent Supreme Court Case ruling in Wyeth v. Levine. This report offers an original proposal that would both protect innovation and offer real victims a remedy- an alternative compensation program for consumers injured by unknown drug side effects.
Source: www.medicalnewstoday.comEyeforpharma's Patient Relationship Marketing And Adherence Summit To Take Place In London 9-10 June 09 eyeforpharma's Patient Relationship Marketing and Adherence Summit is back for the 6th year. Taking your valuable feedback into account, we focused our research on topics that will make a difference for your business this year.
Source: www.medicalnewstoday.comClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer Michael Bruns brings extensive experience in enterprise technology to rapidly expanding Chicago-based clinical software company; will lead company's global sales and services organization as well as manage the company's financial department. (PRWeb Mar 19, 2009)
Read the full story at http://www.prweb.com/releases/2009/03/prweb2247864.htm
Source: www.prweb.comCVS Plan To Close Some Retail Clinics Draws Criticism CVS Caremark plans to close 16% of its retail health clinics until next flu season, a move that critics say will affect access to affordable health care for the uninsured, the Tribune/South Florida Sun-Sentinel reports.
Source: www.medicalnewstoday.comNew Genre Of Sugar-coated "quantum Dots" For Drug Delivery - Journal Of The American Chemical Society Scientists in Switzerland are reporting an advance that could help tap the much-heralded potential of "quantum dots" - nanocrystals that glow when exposed to ultraviolet light - in the treatment of cancer and other diseases. They are publishing the first study showing that giving quantum dots an icing-like cap of certain sugars makes these nanoparticles accumulate in the liver but not other parts of the body.
Source: www.medicalnewstoday.comHDMA Applauds The Nomination Of Dr. Margaret Hamburg As Commissioner Of The U.S. Food And Drug Administration The Healthcare Distribution Management Association (HDMA), the national association representing primary healthcare distributors, commends President Barack Obama on his nomination of Dr. Margaret Hamburg as Commissioner, U.S. Food and Drug Administration (
FDA). "We applaud the nomination of Dr.
Source: www.medicalnewstoday.comPharmaceutical Safety Company Shares Insight Into European Quality Assurance Regulations Drug Safety Alliance (DSA), a global leader in pharmaceutical safety and pharmacovigilance, was invited to share their extensive insight into quality assurance protocols in Europe with the Regulatory Affairs Professionals Society (RAPS) at their annual conference held recently in Boston.
Source: www.medicalnewstoday.com
# posted by Network @ 2:15 PM
